GTP Bioways is happy to announce our participation in BEBPA‘s 12th Annual Host Cell Protein (HCP) Conference, scheduled from May 14th to 16th. This event serves as a dynamic platform for industry leaders, researchers, and regulatory authorities to explore critical facets of HCP analysis, regulatory dynamics, and bioprocessing methodologies.
Exploring Key Themes in HCP Analysis
HCPs, integral proteins originating from cells used in biopharmaceutical production, pose inherent risks of contaminating the final drug product. Consequently, the conference is designed to address these challenges through engaging sessions, interactive workshops, and insightful discussions. Attendees can expect an immersive exploration of various topics, including ELISA development, control strategies, product stability assessment, evolving HCP identification and quantification, regulatory compliance, and cutting-edge technologies for analysis.
Discover Our HCP risk Management expertise
Vincent Rivera, Director of GTP Bioways’ Immuno Business Unit, will be virtually participating in the conference.
Not only do we provide HCP risk management expertise, we also offer a continuum of services from Cell Line Development to aseptic Filling, our support spans the entire process, including process development and GMP manufacturing in microbial and mammalian systems.
Should you wish to glean further insights into GTP Bioways’CDMO services, please don’t hesitate to reach out to us! We hope you’ll enjoy the HCP conference as much as we will!
